Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54)
Release Date: August 8, 2007
Announcement Number: RFA-NS-08-002
Application Receipt Date:
November 19, 2007
Letter of Intent Date: October 22, 2007
Funding Contact: John Porter, Ph.D.
Program Area: Neurogenetics
Brief Description:
This funding opportunity announcement (FOA) solicits new (type 1) and competitive renewal (type 2) applications for the support
of Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. Successful applicants will join a network of
existing Centers to foster the translation of new scientific findings and technological developments into novel treatments
for the muscular dystrophies. Each Center may contain a mixture of basic, translational, or clinical research, as long as
efforts are directed toward the steps required for therapeutic development, including therapeutic target identification, characterization,
and validation, development of diagnostics and biomarkers to characterize or stratify patient populations, in vitro assay
development, animal model development and characterization, candidate therapeutic efficacy screening, preclinical therapeutic
optimization and FDA-required activities leading to an investigational new drug (IND) application, clinical infrastructure
and studies in support of a clinical trial, patient-oriented natural history studies, and early stage clinical trials for
one or more types of muscular dystrophy.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |